MALINVERNO, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 1.651
EU - Europa 865
AS - Asia 318
SA - Sud America 6
Totale 2.840
Nazione #
US - Stati Uniti d'America 1.635
IT - Italia 229
DE - Germania 157
SE - Svezia 129
SG - Singapore 127
IE - Irlanda 108
CN - Cina 98
AT - Austria 69
RU - Federazione Russa 68
GB - Regno Unito 28
HK - Hong Kong 24
CA - Canada 16
MY - Malesia 16
BE - Belgio 15
ID - Indonesia 15
DK - Danimarca 11
NL - Olanda 11
UA - Ucraina 11
IN - India 10
FI - Finlandia 9
FR - Francia 9
VN - Vietnam 9
TR - Turchia 6
MM - Myanmar 4
AR - Argentina 3
CZ - Repubblica Ceca 3
TW - Taiwan 3
BR - Brasile 2
GR - Grecia 2
KR - Corea 2
LT - Lituania 2
NO - Norvegia 2
CO - Colombia 1
EE - Estonia 1
IR - Iran 1
JP - Giappone 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
Totale 2.840
Città #
Ann Arbor 496
Chandler 167
Frankfurt am Main 145
Fairfield 131
Singapore 116
Dublin 105
Wilmington 99
Woodbridge 82
Ashburn 69
Seattle 66
Vienna 66
Milan 57
New York 55
Houston 46
Cambridge 42
Shanghai 39
Princeton 36
Santa Clara 35
Dearborn 29
Hong Kong 24
Lawrence 18
Rome 18
Penang 16
Jakarta 15
Brussels 14
Nanjing 13
Altamura 11
Jacksonville 11
Los Angeles 11
San Diego 10
Helsinki 8
London 8
Toronto 7
Boardman 6
Buffalo 6
Fremont 5
Lissone 5
Pune 5
Appiano Gentile 4
Dong Ket 4
Kocaeli 4
Udine 4
Andover 3
Bari 3
Biassono 3
Bologna 3
Brno 3
Changsha 3
Desio 3
Dongguan 3
Edmonton 3
Falls Church 3
Garbagnate Milanese 3
Genoa 3
Hebei 3
Jinan 3
Kunming 3
Modena 3
New Taipei 3
Paris 3
Shenyang 3
Vigevano 3
Athens 2
Beijing 2
Bergamo 2
Bonndorf 2
Carate Brianza 2
Castelnuovo Scrivia 2
Catania 2
Dalmine 2
Fiumefreddo di Sicilia 2
Florence 2
Franklin 2
Groningen 2
Guangzhou 2
Guiyang 2
Hangzhou 2
Lucera 2
Meda 2
Monza 2
Mumbai 2
Nanchang 2
New Delhi 2
Ningbo 2
Norwalk 2
Oslo 2
Ottawa 2
Padova 2
Pavia 2
Rho 2
Sacramento 2
São Paulo 2
Tianjin 2
Triggiano 2
Wuhan 2
Amsterdam 1
Ankara 1
Arnsberg 1
Avigliana 1
Belsize Park 1
Totale 2.239
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 424
A worldwide cross-ethnic study of quality of life in patients with PBC: Attitude or latitude? 299
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 193
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 189
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 183
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis 177
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 177
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach 176
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 166
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 165
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 151
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 109
Comprehensive review of autoantibodies in patients with hyper-IgM syndrome 94
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 90
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 86
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 84
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 73
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 64
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 58
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 22
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 21
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 15
Totale 3.016
Categoria #
all - tutte 11.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.485


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020231 0 0 0 0 0 40 48 33 39 32 30 9
2020/2021612 12 12 102 37 37 97 61 66 43 40 60 45
2021/2022408 44 45 57 39 31 27 10 33 19 17 29 57
2022/2023653 60 196 63 70 73 56 25 31 42 9 24 4
2023/2024412 16 12 9 37 38 110 71 13 20 30 12 44
2024/2025333 45 77 66 42 72 31 0 0 0 0 0 0
Totale 3.016